|
1
|
Dickie L, Johnson CH, Adams S and Serban
N: Solid tumor rules. Effective with Cases Diagnosed 1/1/2018 and
Forward. National Cancer; Rockville, MD: 2021, https://seer.cancer.gov/tools/solidtumor/STM.pdfMarch
9–2023
|
|
2
|
Report WG: International rules for
multiple primary cancers (ICD-0 third edition). Eur J Cancer Prev.
14:307–308. 2005. View Article : Google Scholar
|
|
3
|
American Cancer Society, . Cancer Facts
& Figures 2009. American Cancer Society; Atlanta, GA: 2019,
https://www.cancer.org/research/cancer-facts-statistics/all-cancer-facts-figures/cancer-facts-figures-2009.htmlApril
6–2023
|
|
4
|
Cybulski C, Nazarali S and Narod SA:
Multiple primary cancers as a guide to heritability. Int J Cancer.
135:1756–1763. 2014. View Article : Google Scholar
|
|
5
|
Chan GHJ, Ong PY, Low JJH, Kong HL, Ow
SGW, Tan DSP, Lim YW, Lim SE and Lee SC: Clinical genetic testing
outcome with multi-gene panel in Asian patients with multiple
primary cancers. Oncotarget. 9:30649–30660. 2018. View Article : Google Scholar
|
|
6
|
Harvengt J, Lumaka A, Fasquelle C, Caberg
JH, Mastouri M, Janssen A, Palmeira L and Bours V: HIDEA syndrome:
A new case report highlighting similarities with ROHHAD syndrome.
Front Genet. 14:11377672023. View Article : Google Scholar
|
|
7
|
Richards S, Aziz N, Bale S, Bick D, Das S,
Gastier-Foster J, Grody WW, Hegde M, Lyon E, Spector E, et al:
Standards and guidelines for the interpretation of sequence
variants: A joint consensus recommendation of the American college
of medical genetics and genomics and the association for molecular
pathology. Genet Med. 17:405–424. 2015. View Article : Google Scholar
|
|
8
|
Backenroth D, Homsy J, Murillo LR,
Glessner J, Lin E, Brueckner M, Lifton R, Goldmuntz E, Chung WK and
Shen Y: CANOES: Detecting rare copy number variants from whole
exome sequencing data. Nucleic Acids Res. 42:e972014. View Article : Google Scholar
|
|
9
|
Riggs ER, Andersen EF, Cherry AM, Kantarci
S, Kearney H, Patel A, Raca G, Ritter DI, South ST, Thorland EC, et
al: Technical standards for the interpretation and reporting of
constitutional copy number variants: A joint consensus
recommendation of the American college of medical genetics and
genomics (ACMG) and the clinical genome resource (ClinGen). Genet
Med. 22:245–257. 2020. View Article : Google Scholar
|
|
10
|
Li MM, Datto M, Duncavage EJ, Kulkarni S,
Lindeman NI, Roy S, Tsimberidou AM, Vnencak-Jones CL, Wolff DJ,
Younes A and Nikiforova MN: Standards and guidelines for the
interpretation and reporting of sequence variants in cancer. J Mol
Diagn. 19:4–23. 2017. View Article : Google Scholar
|
|
11
|
Blokzijl F, Janssen R, van Boxtel R and
Cuppen E: MutationalPatterns: Comprehensive genome-wide analysis of
mutational processes. Genome Med. 10:332018. View Article : Google Scholar
|
|
12
|
Alexandrov LB, Nik-Zainal S, Wedge DC,
Aparicio SA, Behjati S, Biankin AV, Bignell GR, Bolli N, Borg A,
Børresen-Dale AL, et al: Signatures of mutational processes in
human cancer. Nature. 500:415–421. 2013. View Article : Google Scholar
|
|
13
|
Nielsen M, Joerink-van de Beld MC, Jones
N, Vogt S, Tops CM, Vasen HFA, Sampson JR, Aretz S and Hes FJ:
Analysis of MUTYH genotypes and colorectal phenotypes in patients
with MUTYH-associated polyposis. Gastroenterology. 136:471–476.
2009. View Article : Google Scholar
|
|
14
|
Barreiro RAS, Sabbaga J, Rossi BM, Achatz
MIW, Bettoni F, Camargo AA, Asprino PF and Galante PAF: Monoallelic
deleterious MUTYH germline variants as a driver for tumorigenesis.
J Pathol. 256:214–222. 2022. View Article : Google Scholar
|
|
15
|
Abou Tayoun AN, Pesaran T, DiStefano MT,
Oza A, Rehm HL, Biesecker LG and Harrison SM; ClinGen Sequence
Variant Interpretation Working Group (ClinGen SVI), :
Recommendations for interpreting the loss of function PVS1 ACMG/AMP
variant criterion. Hum Mutat. 39:1517–1524. 2018. View Article : Google Scholar
|
|
16
|
Whitworth J, Smith PS, Martin JE, West H,
Luchetti A, Rodger F, Clark G, Carss K, Stephens J, Stirrups K, et
al: Comprehensive cancer-predisposition gene testing in an adult
multiple primary tumor series shows a broad range of deleterious
variants and atypical tumor phenotypes. Am J Hum Genet. 103:3–18.
2018. View Article : Google Scholar
|
|
17
|
Liu YL, Cadoo KA, Mukherjee S, Khurram A,
Tkachuk K, Kemel Y, Maio A, Belhadj S, Carlo MI, Latham A, et al:
Multiple primary cancers in patients undergoing tumor-normal
sequencing define novel associations. Cancer Epidemiol Biomarkers
Prev. 31:362–371. 2022. View Article : Google Scholar
|
|
18
|
McGuigan A, Whitworth J, Andreou A, Hearn
T, Tischkowitz M and Maher ER: Multilocus inherited neoplasia
allele syndrome (MINAS): An update. Eur J Hum Genet. 30:265–270.
2022. View Article : Google Scholar
|
|
19
|
Aston CE, Ralph DA, Lalo DP, Manjeshwar S,
Gramling BA, DeFreese DC, West AD, Branam DE, Thompson LF, Craft
MA, et al: Oligogenic combinations associated with breast cancer
risk in women under 53 years of age. Hum Genet. 116:208–221. 2005.
View Article : Google Scholar
|
|
20
|
Renieri A, Mencarelli MA, Cetta F,
Baldassarri M, Mari F, Furini S, Piu P, Ariani F, Dragani TA and
Frullanti E: Oligogenic germline mutations identified in early
non-smokers lung adenocarcinoma patients. Lung Cancer. 85:168–1674.
2014. View Article : Google Scholar
|
|
21
|
Weischer M, Heerfordt IM, Bojesen SE,
Eigentler T, Garbe C, Röcken M, Hölmich LR, Schmidt H, Klyver H,
Bastholt L and Nordestgaard BG: CHEK2*1100delC and risk of
malignant melanoma: Danish and German studies and meta-analysis. J
Invest Dermatol. 132:299–303. 2012. View Article : Google Scholar
|
|
22
|
AlDubayan SH, Pyle LC, Gamulin M, Kulis T,
Moore ND, Taylor-Weiner A, Hamid AA, Reardon B, Wubbenhorst B,
Godse R, et al: Association of inherited pathogenic variants in
checkpoint kinase 2 (CHEK2) with susceptibility to testicular germ
cell tumors. JAMA Oncol. 5:514–522. 2019. View Article : Google Scholar
|
|
23
|
Stolarova L, Kleiblova P, Janatova M,
Soukupova J, Zemankova P, Macurek L and Kleibl Z: CHEK2 germline
variants in cancer predisposition: Stalemate rather than checkmate.
Cells. 9:26752020. View Article : Google Scholar
|
|
24
|
Xu J, Zheng SL, Komiya A, Mychaleckyj JC,
Isaacs SD, Hu JJ, Sterling D, Lange EM, Hawkins GA, Turner A, et
al: Germline mutations and sequence variants of the macrophage
scavenger receptor 1 gene are associated with prostate cancer risk.
Nat Genet. 32:321–325. 2002. View
Article : Google Scholar
|
|
25
|
Orloff M, Peterson C, He X, Ganapathi S,
Heald B, Yang YR, Bebek G, Romigh T, Song JH, Wu W, et al: Germline
mutations in MSR1, ASCC1, and CTHRC1 in patients with barrett
esophagus and esophageal adenocarcinoma. JAMA. 306:410–419. 2011.
View Article : Google Scholar
|
|
26
|
Wen WX, Soo JS, Kwan PY, Hong E, Khang TF,
Mariapun S, Lee CS, Hasan SN, Rajadurai P, Yip CH, et al: Germline
APOBEC3B deletion is associated with breast cancer risk in an Asian
multi-ethnic cohort and with immune cell presentation. Breast
Cancer Res. 18:562016. View Article : Google Scholar
|
|
27
|
Vega-Stromberg T: Chemotherapy-induced
secondary malignancies. J Infus Nurs. 26:3532003. View Article : Google Scholar
|
|
28
|
Freire Chadrina M, Martin M and Segers K:
Sepulchre. Coinheritance of pathogenic variants in ATM and BRCA2 in
families with multiple cancers: A case series (Internet).
2022.(cited 2023 Feb 23).
|
|
29
|
Vietri MT, Caliendo G, D'Elia G, Resse M,
Casamassimi A, Minucci PB, Dello Ioio C, Cioffi M and Molinari AM:
Five Italian families with two mutations in BRCA genes. Genes
(Basel). 11:14512020. View Article : Google Scholar
|
|
30
|
Huang W, Bian J, Qian X, Shao L, Li H,
Zhang L and Wang L: Case report: Coinheritance of germline
mutations in APC and BRCA1 in colorectal cancer. Front Oncol.
11:6583892021. View Article : Google Scholar
|
|
31
|
Borde J, Ernst C, Wappenschmidt B,
Niederacher D, Weber-Lassalle K, Schmidt G, Hauke J, Quante AS,
Weber-Lassalle N, Horváth J, et al: Performance of breast cancer
polygenic risk scores in 760 female CHEK2 germline mutation
carriers. J Natl Cancer Inst. 113:893–899. 2020. View Article : Google Scholar
|
|
32
|
Potorac I, Laterre M, Malaise O, Nechifor
V, Fasquelle C, Colleye O, Detrembleur N, Verdin H, Symoens S, De
Baere E, et al: The role of MCM9 in the etiology of sertoli
cell-only syndrome and premature ovarian insufficiency. J Clin Med.
12:9902023. View Article : Google Scholar
|
